CureVac N.V. (CVAC)
Jan 6, 2026 - CVAC was delisted (reason: acquired by BNTX)
4.660
-0.010 (-0.21%)
Inactive · Last trade price on Jan 5, 2026
CureVac Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 70.74 | 535.18 | 53.76 | 67.42 | 102.99 | 48.87 | |
Revenue Growth (YoY) | -86.98% | 895.54% | -20.26% | -34.54% | 110.74% | 180.61% |
Cost of Revenue | 12.05 | -88.83 | -141.37 | -183.99 | -238.2 | -14.17 |
Gross Profit | 58.69 | 624.01 | 195.12 | 251.41 | 341.19 | 63.04 |
Selling, General & Admin | -88.33 | -74.14 | -95.67 | -107 | -102.15 | -54.29 |
Research & Development | -154.86 | -153.03 | -115.72 | -62.55 | -815.91 | -113.81 |
Other Operating Expenses | 327.38 | -24.5 | 7.8 | 36.66 | 640.99 | 23.58 |
Total Operating Expenses | 84.18 | -251.67 | -203.6 | -132.88 | -277.06 | -144.51 |
Operating Income | 166.98 | 194.68 | -291.21 | -249.46 | -412.26 | -109.82 |
Interest Income | 14.43 | 14.03 | 16.73 | 4.01 | 10.1 | 2.07 |
Interest Expense | -7.01 | -0.83 | -2.49 | -3.71 | -10.34 | -22.1 |
Total Non-Operating Income (Expense) | 7.42 | 13.2 | 14.24 | 0.3 | -0.24 | -20.03 |
Pretax Income | 174.4 | 207.88 | -276.97 | -249.16 | -412.5 | -129.85 |
Provision for Income Taxes | -28.57 | -28.7 | -0.2 | 0.13 | 0.78 | 0.73 |
Net Income | 145.82 | 179.19 | -277.17 | -249.03 | -411.72 | -129.12 |
Net Income to Common | 145.82 | 179.19 | -277.17 | -249.03 | -411.72 | -129.12 |
Net Income Growth | 59.73% | - | - | - | - | - |
Shares Outstanding (Basic) | 356 | 224 | 221 | 189 | 186 | 132 |
Shares Outstanding (Diluted) | 356 | 225 | 221 | 189 | 186 | 132 |
Shares Change (YoY) | 72.14% | 1.97% | 16.84% | 1.65% | 40.71% | 36.72% |
EPS (Basic) | 0.41 | 0.80 | -1.26 | -1.32 | -2.21 | -0.98 |
EPS (Diluted) | 0.41 | 0.80 | -1.26 | -1.32 | -2.21 | -0.98 |
EPS Growth | -16.33% | - | - | - | - | - |
Free Cash Flow | - | 87.54 | -320.21 | -374.2 | -857.35 | 486.07 |
Free Cash Flow Per Share | - | 0.39 | -1.45 | -1.98 | -4.61 | 3.68 |
Gross Margin | 82.96% | 116.60% | 362.97% | 372.91% | 331.28% | 129.00% |
Operating Margin | 236.04% | 36.38% | -541.70% | -370.00% | -400.29% | -224.70% |
Profit Margin | 206.14% | 33.48% | -515.58% | -369.37% | -399.76% | -264.21% |
FCF Margin | - | 16.36% | -595.65% | -555.03% | -832.46% | 994.61% |
EBITDA | 166.98 | 213.49 | -267.82 | -225.72 | -396.59 | -99.14 |
EBITDA Margin | 236.04% | 39.89% | -498.20% | -334.79% | -385.08% | -202.87% |
EBIT | 166.98 | 194.68 | -291.21 | -249.46 | -412.26 | -109.82 |
EBIT Margin | 236.04% | 36.38% | -541.70% | -370.00% | -400.29% | -224.70% |
Effective Tax Rate | -16.38% | -13.80% | 0.07% | -0.05% | -0.19% | -0.56% |